Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Lock

Showing results (61-70 of 167) with videos related to

Pageof 17
Sort By:
Current Oncology (Toronto, Ont.)|February 12, 2021
Cost Minimization Analysis of Hypofractionated RadiotherapyHannah L Yaremko, Gordon E Locke, Ronald Chow, et al.
Cureus|August 13, 2019
Phase III Randomized Pair Comparison of a Barrier Film vs. Standard Skin Care in Preventing Radiation Dermatitis in Post-lumpectomy Patients with Breast Cancer Receiving Adjuvant Radiation TherapyAndrew Cl Lam, Edward Yu, Danielle Vanwynsberghe, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 7, 2021
Cost-effectiveness analysis of olanzapine-containing antiemetic therapy for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) in highly emetogenic chemotherapy (HEC) patientsRonald Chow, Leonard Chiu, Jørn Herrstedt, et al.
Palliative & Supportive Care|September 16, 2022
Prophylaxis and treatment of cancer-related dyspnea with pharmacologic agents: A systematic review and network meta-analysisRonald Chow, David Hui, Saverio Caini, et al.
Radiation Oncology (London, England)|January 9, 2008
Comparing two strategies of dynamic intensity modulated radiation therapy (dIMRT) with 3-dimensional conformal radiation therapy (3DCRT) in the hypofractionated treatment of high-risk prostate cancerJasper Yuen, George Rodrigues, Kristina Trenka, et al.
Expert Review of Vaccines|November 15, 2021
Update on CVD 103-HgR single-dose, live oral cholera vaccineJames McCarty, Lisa Bedell, Paul-Andre De Lame, et al.
Future Oncology (London, England)|September 2, 2016
A multivariable model to predict survival for patients with hepatic carcinoma or liver metastasis receiving radiotherapyJason Vickress, Michael Lock, Simon Lo, et al.
Future Oncology (London, England)|September 1, 2016
Computed tomography imaging assessment of postexternal beam radiation changes of the liverMichael Lock, Ashkan A Malayeri, Omar Y Mian, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 2024
Helical Tomotherapy Versus 3-Dimensional Conformal Radiation Therapy in High-Risk Prostate Cancer: A Phase 3 Randomized Controlled TrialSoumyajit Roy, Robert MacRae, Scott Grimes, et al.
Clinical and Vaccine Immunology : CVI|November 1, 2013
Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR, prepared from new master and working cell banksWilbur H Chen, Richard N Greenberg, Marcela F Pasetti, et al.
Pageof 17

Showing results (61-70 of 167) with videos related to

Sort By:
Pageof 17
Current Oncology (Toronto, Ont.)|February 12, 2021
Cost Minimization Analysis of Hypofractionated RadiotherapyHannah L Yaremko, Gordon E Locke, Ronald Chow, et al.
Cureus|August 13, 2019
Phase III Randomized Pair Comparison of a Barrier Film vs. Standard Skin Care in Preventing Radiation Dermatitis in Post-lumpectomy Patients with Breast Cancer Receiving Adjuvant Radiation TherapyAndrew Cl Lam, Edward Yu, Danielle Vanwynsberghe, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 7, 2021
Cost-effectiveness analysis of olanzapine-containing antiemetic therapy for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) in highly emetogenic chemotherapy (HEC) patientsRonald Chow, Leonard Chiu, Jørn Herrstedt, et al.
Palliative & Supportive Care|September 16, 2022
Prophylaxis and treatment of cancer-related dyspnea with pharmacologic agents: A systematic review and network meta-analysisRonald Chow, David Hui, Saverio Caini, et al.
Radiation Oncology (London, England)|January 9, 2008
Comparing two strategies of dynamic intensity modulated radiation therapy (dIMRT) with 3-dimensional conformal radiation therapy (3DCRT) in the hypofractionated treatment of high-risk prostate cancerJasper Yuen, George Rodrigues, Kristina Trenka, et al.
Expert Review of Vaccines|November 15, 2021
Update on CVD 103-HgR single-dose, live oral cholera vaccineJames McCarty, Lisa Bedell, Paul-Andre De Lame, et al.
Future Oncology (London, England)|September 2, 2016
A multivariable model to predict survival for patients with hepatic carcinoma or liver metastasis receiving radiotherapyJason Vickress, Michael Lock, Simon Lo, et al.
Future Oncology (London, England)|September 1, 2016
Computed tomography imaging assessment of postexternal beam radiation changes of the liverMichael Lock, Ashkan A Malayeri, Omar Y Mian, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 2024
Helical Tomotherapy Versus 3-Dimensional Conformal Radiation Therapy in High-Risk Prostate Cancer: A Phase 3 Randomized Controlled TrialSoumyajit Roy, Robert MacRae, Scott Grimes, et al.
Clinical and Vaccine Immunology : CVI|November 1, 2013
Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR, prepared from new master and working cell banksWilbur H Chen, Richard N Greenberg, Marcela F Pasetti, et al.
Pageof 17